Tranexamic acid reduces perioperative blood transfusions following open radical cystectomy - a propensity-score matched analysis
- PMID: 39115584
- PMCID: PMC11310255
- DOI: 10.1007/s00345-024-05168-x
Tranexamic acid reduces perioperative blood transfusions following open radical cystectomy - a propensity-score matched analysis
Abstract
Purpose: Radical cystectomy is associated with bleeding and high transfusion rates, presenting challenges in patient management. This study investigated the prophylactic use of tranexamic acid during radical cystectomy.
Methods: All consecutive patients treated with radical cystectomy at a tertiary care university center were included from a prospectively maintained database. After an institutional change in the cystectomy protocol patients received 1 g of intravenous bolus of tranexamic acid as prophylaxis. To prevent bias, propensity score matching was applied, accounting for differences in preoperative hemoglobin, neoadjuvant chemotherapy, tumor stage, and surgeon experience. Key outcomes included transfusion rates, complications, and occurrence of venous thromboembolism.
Results: In total, 420 patients were included in the analysis, of whom 35 received tranexamic acid. After propensity score matching, 32 patients and 32 controls were matched with regard to clinicopathologic characteristics. Tranexamic acid significantly reduced the number of patients who received transfusions compared to controls (19% [95%-Confidence interval = 8.3; 37.1] vs. 47% [29.8; 64.8]; p = 0.033). Intraoperative and postoperative transfusion rates were lower with tranexamic acid, though not statistically significant (6% [1.5; 23.2] vs. 19% [8.3; 37.1], and 16% [6.3; 33.7] vs. 38% [21.9; 56.1]; p = 0.257 and p = 0.089, respectively). The occurrence of venous thromboembolism did not differ significantly between the groups (9% [2.9; 26.7] vs. 3% [0.4; 20.9]; p = 0.606).
Conclusion: Prophylactic tranexamic administration, using a simplified preoperative dosing regimen of 1 g as a bolus, significantly lowered the rate of blood transfusion after cystectomy. This exploratory study indicates the potential of tranexamic acid in enhancing outcomes of open radical cystectomy.
Keywords: Blood transfusion; Cystectomy; Tranexamic acid; Venous thromboembolism.
© 2024. The Author(s).
Figures
References
-
- Bruins HM, Veskimae E, Hernandez V et al (2020) The importance of Hospital and Surgeon volume as major determinants of morbidity and mortality after radical cystectomy for bladder Cancer: a systematic review and recommendations by the European Association of Urology Muscle-Invasive and metastatic bladder Cancer Guideline Panel. Eur Urol Oncol 3:131–144 - PubMed
-
- Linder BJ, Frank I, Cheville JC et al (2013) The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 63:839–845 - PubMed
-
- Myers A, Frank I, Shah Paras H et al (2023) Intraoperative blood transfusion is Associated with increased risk of venous Thromboembolism after Radical Cystectomy. J Urol 209:525–531 - PubMed
-
- Uysal D, Egen L, Grilli M et al (2021) Impact of perioperative blood transfusions on oncologic outcomes after radical cystectomy: a systematic review and meta-analysis of comparative studies. Surg Oncol 38:101592 - PubMed
-
- Buchner A, Grimm T, Schneevoigt BS et al (2017) Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage. Scandinavian J Urol 51:130–136 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
